# Assessment of Protective Effect of JOINS on Cartilage in Knee Osteoarthritis

> **NCT01293955** · PHASE4 · COMPLETED · sponsor: **SK Chemicals Co., Ltd.** · enrollment: 76 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** JOINS 200mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01293955
- **Lead sponsor:** SK Chemicals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2015-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01293955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01293955, "Assessment of Protective Effect of JOINS on Cartilage in Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01293955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*